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This study shows that high methylmercury concentrations are cytotoxic for Styela plicata hemocytes,
whereas sublethal concentrations affect immunocyte responses. Moreover, hemocytes exposed to
the xenobiotic present a significantly enhanced phenoloxidase activity as revealed in the hemocyte
lysate supernatant compared with the control. Although the cytotoxic activity of S. plicata hemocytes
toward rabbit erythrocytes is a PO-dependent cell-target reaction due to quinone products, it was
significantly decreasedby suitablemethylmercury concentrations in themedium.The same xenobiotic
concentrations decreased the hemocyte phagocytic activity toward yeast. In both the responses cell-
target contacts could be affected by methylmercury, whereas the releasing capacity appeared to be
unchanged, as indicated by hemocyte PO-release in the medium. Finally, changes in hemocyte shape
and spreading capacity were shown. On the basis of the present results, Styela plicata hemocyte
responses could be an additional immunotoxicology test using a microplate method that reveals cell
morphological changes and spreading capacity. Copyright  2007 John Wiley & Sons, Ltd.
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INTRODUCTION
Pollution by heavy metals is a major risk in aquatic
ecosystems, where high concentrations cause adverse
biological effects, including changes in immune function
of invertebrate and vertebrate species.1 – 3 In the marine
environment, although mercury concentration in the water
column and sediments may be low, filter feeding invertebrates
accumulate this metal in their tissues.4 In addition, biological
processes mediate mercury methylation, transforming the
metal into methylmercury5 – 9 which is the most toxic form
due to the methyl group that facilitates cell penetration and
interaction with proteins, interfering with their synthesis and
leading to lipid peroxidation.10 Methylmercury is capable of
blocking the binding sites of enzymes while they interfere
with the incorporation of thymidine into DNA.7
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Mercury pollution in aquatic systems necessitates knowl-
edge of the biological effects of methylmercury,9,11 – 13 which
can be responsible for changes in immune functions1 – 3,14
of animals that accumulate heavy metals. In addition, with
the increasing interest in using organisms as bioindicators
for marine environmental chronic stress,15 – 17 cellular and
functional parameters of the immune system in many sen-
tinel species can represent anticipatory signals in monitoring
organisms and their environment.18,19 Ascidians filter large
amounts of water, accumulate toxicants in their tissues,
including heavy metals, and are considered good indicators
of water quality.20,21 However little is known about the effects
of heavy metals on biological functions. Cima et al.22 reported
that a treatment with organotin compounds decreased the
viability of Styela plicata embryos, and other authors have
shown that copper and tributyltin (TBT) affect cytotoxicity23
and phagocytosis.23 – 25
The general functional features of invertebrate and
vertebrate phagocytes make phagocytic function attractive for
immunotoxicology studies. Phagocytosis can be affected by
environmental xenobiotics.18,24,26 – 31 Copper alters actin and
fibronectin organization of mussel hemocytes,32 and heavy
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metals impair the phagocytic activity of coelomocytes from
terrestrial and aquatic annelid species;33 – 35 chronic exposure
to low doses of metallic mercury impaired the chemotactic
activity of vertebrate polymorphonuclear leukocytes.36,37
The cascade reaction named ‘prophenoloxidase activat-
ing system’ (proPO) is an invertebrate melanogenic pathway
involved in immune responses38 – 40 challenged by bacterial ß-
1,3 glucans or lipopolysaccharides. A recognition phase starts
a protease cascade that activates hemocyte prophenoloxidase,
and the subsequent phenoloxidase (PO) pathway produces
cytotoxic quinones and radical oxygen intermediates.41 Ascid-
ian PO is a o-diphenoloxidase, detected in hemocyte lysates
and identified in hemocytes by cytochemical analysis.42
In ascidians hemocyte, immunoreactivity could be affected
by sublethal methylmercury concentration in the organism
and/or in sea water. In the present paper, phagocytic and
phenoloxidase activities of Styela plicata hemocytes appear
to be affected by methylmercury. This xenobiotic, at high
concentrations, is cytotoxic for hemocytes in vitro, whereas
at sublethal concentration it affects S. plicata immunocyte
activities, causing immunosuppression, as revealed by
assays of phenoloxidase-dependent cytotoxic activity and
phagocytosis. Finally, changes in hemocyte morphology and
spreading capacity were shown.
EXPERIMENTAL
Chemicals
Methylmercury was first dissolved at 10−3 M concentration
in marine solution (MS: 12 mM CaCl2·6H2O; 11 mM KCl;
26 mM MgCl26H2O; 45 mM Tris; 38 mM HCl; 0.45 M NaCl;
pH 7.4). Stock solutions were then diluted in MS to the final
concentrations of 10−8, 10−7, 10−6, 10−5, 10−4 M. Preliminary
assays showed that the cell viability did not change as an effect
of the methylmercury solvent. Unless otherwise reported, all
the chemicals used were from Sigma (St Louis, MO, USA).
Tunicates and preparation of hemolymph
Ascidians (25–30 g wet weight) were collected from Mazara
del Vallo Harbour (Sicily, Italy), maintained in tanks with
aerated sea water at 15 ◦C, and fed every second day with
a marine invertebrate diet (Hawaiian Marine Imports Inc.,
Houston, TX, USA).
The tunic was cleaned from epiphytes and sterilized
with ethyl alcohol; the incurrent siphon was incised and
the exuding hemolymph was collected into sterile tubes
containing a 5-fold excess of calcium/magnesium-free
artificial sea water (FSW: 9 mM KCl; 0.15 M NaCl; 29 mM
Na2SO4, NaHCO3, pH 7.4) with 10 mM EDTA (FSW-EDTA)
as anticoagulant (1 : 9 medium : hemolymph ratio), on ice.
After centrifuging at 400g for 10 min at 4 ◦C, the hemocytes
were washed three times in sterile FSW-EDTA. Appropriate
controls showed that hemocyte mortality evaluated by the
Trypan blue test was lower than 5%.
Hemocyte lysate supernatant (HLS)
Hemocytes (3 × 106 ml−1) in ice-cold FSW-EDTA were
centrifuged and suspended in a same volume of 10 mM
cacodylate buffer pH 9.0 (CAC) to be sonicated at 4 ◦C for 60 s
(Branson, model B15, Danbury, CT, USA). The cell lysate was
centrifuged at 27 000 g for 20 min at 4 ◦C and the resulting
hemocyte lysate supernatant (HLS) used for the assays.
Assay of PO activity
HLS phenoloxidase (PO) activity was measured spec-
trophotometrically by recording the product obtained
from the reaction between DOPA-quinone and 3-methyl-
2-benzothiazolinone hydrazone hydrochloride (MBTH).43
Briefly, 40 µl of HLS were incubated 20 min at 20 ◦C with 150 µl
cacodilate (CAC) buffer, and 150 ml MBTH reaction mixture,
containing 0.49 ml of buffer B (4% N,N′dimethylformamide
in CAC buffer), 0.2 ml of 5 mM dihydroxyphenylalanine
(L-DOPA) and 0.3 ml of 20.7 mM MBTH in buffer B (DOPA-
MBTH). After incubation, the reaction product was detected
at 505 nm.
The effect of protease as a proPO activator (bovine pancreas
trypsin type III) was examined by adding 150 µl of enzyme
(1 mg ml−1 in CAC) to 40 µl HLS. After 20 min preincubation,
150 µl of L-DOPA were added into the reaction mixture. The
spectrophotometric measures were compared with controls,
in which protease solutions were substituted by 150 µl of
CAC-buffer. The PO activity was expressed as units (U) for
min where 1 U = 0.001 DA505 min−1 mg−1 protein.
Protein determination
Protein content was determined using the Bradford method,44
with bovine serum albumin (BSA) as a standard. The HLS
protein content ranged from 20 to 100 µg ml−1.
Cytochemical PO assay
Hemocytes suspended in MS were layered on a cleaned
pyrogen-free (heated at 180 ◦C for 4 h) glass coverslip
and incubated for 30 min at 20 ◦C. Cell monolayers were
washed three times with FSW and fixed for 30 min with
1% glutaraldehyde in MS containing 1% sucrose. Finally,
after three washings in distilled water, cell monolayers were
incubated with DOPA-MBTH and observed after 1–8 h using
an inverted microscope. A visible pink product was observed
when MBTH reacted with dopaquinones.43
Hemocyte cytotoxic assay (HCA)
The cytotoxic assay against erythrocytes has been described
previously.48 In brief, 200 µl S. plicata hemocyte suspensions
(1.5 × 106 cells, Effector) in MS were mixed with an equal
volume of freshly prepared rabbit erythrocytes (8 × 106 cells,
REs) in the same medium. The mixture was incubated at
20 ◦C for 1 h, and the amount of the released hemoglobin
was estimated by reading the absorbance at 541 nm in the
supernatants after mixture centrifugation. To obtain 100%
hemolysis, 8 × 106 REs were suspended in 200 µl distilled
water and frozen before being centrifuged at 800 g to separate
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ghosts. When REs were suspended in MS, the spontaneous
hemoglobin release never exceeded 5% of the total release.
The degree of hemolysis was determined according to the
equation:
percentage hemolysis
= measured release − spontaneous release
complete release − spontaneous release × 100
Fluorescence quenching for in vitro
phagocytosis assay
Assays, using Saccharomyces cerevisiae (Sigma) as target,
were performed according to Cooper et al.24 with slight
modifications. The yeast cells were prepared in distilled
water (d.w.) as a 0.25% (w/v, suspension, approximately
1 × 107 cells ml−1) autoclaved for 15 min, washed twice at
2000g at 4 ◦C for 5 min, and incubated for 1 h at 20 ◦C with
eosin Y (4-bromo-fluorescein) at 0.05% final concentration.
Yeast cells were washed four times, suspended to a final
concentration of 0.125% w/v in phosphate buffer saline
(PBS, 6 mM KH2PO4, 30 mM Na2HPO4, 0.11 M NaCl, pH
7.4) and stored at 20 ◦C for a maximum of 2 weeks. Yeast
and 100 µl hemocyte suspension in MS (2.5 × 106 cell/ml)
were placed (v/v) in a 1 ml plastic tube and incubated
(1 : 4 yeast/hemocyte ratio) for 30 min at 20 ◦C with gentle
stirring, then 50 µl of the quenching solution (2 mg ml−1
trypan blue, 2 mg ml−1 crystal violet in 0.02 citrate buffer,
pH 4.4 containing 33 mg ml−1 NaCl) was added. Phagocytes
containing fluoresceinated yeasts were observed under a
microscope equipped with Nomarski differential interference
contrast optics and fluorescent apparatus (450–490 nm filter;
Diaplan, Leika, Wetzlar, D); about 200 cells in each slide were
counted at 800× magnification. The results were expressed as
the percentage of cells containing yeasts.
Exposure of hemocytes to methylmercury in
microplate
Hemocytes were aliquoted (100 µl for well) into 96-well
flat-bottomed cell culture plates, where hemocytes (from
2.5 × 106 cell ml−1 to 7.5 × 106 cell ml−1) were maintained at
15 ◦C for 1 h. For microplate exposures, various concentration
of methylmercury (10−4 –10−8 M, 10 µl FSW per well) were
added to cultured hemocytes. Hemocyte aggregates could
be seen on the well bottom following the treatment, and the
effect of xenobiotic concentration was evaluated by direct
observation.
The hemocyte mortality after 1 h exposure to CH3HgCl at
the concentrations used, as evaluated by the Trypan blue test,
was <5%, whereas cell viability, checked by neutral red vital
stain,45 was >95%.
Hemocytes were layered on a slide and their morphology
observed under Nomarski differential interference contrast
microscopy (Diaplan, Leika, Wetzlar, D).
Statistical analysis
Unless otherwise indicated, the experiments were repeated
three times. The values were the means of three assays
performed in triplicate ± SD. Significance was determined
with Student’s t-test and differences between results were
considered significant at p < 0.05.
RESULTS
Nontoxic doses of methylmercury activate
hemocyte prophenoloxidase
Since hemocyte exposure to methylmercury concentrations
higher than 2 × 10−4 M caused a significant increase in cell
mortality (14% dead and 78% living cells at 10−3 M) the
experiments were performed at sublethal concentrations
(10−4 –10−8 M) when about 95% viable cells and <5% dead
cells were found using neutral red and Trypan blue tests.
Methylmercury activated hemocyte proPO in a dose-
dependent fashion, as shown by the increased PO activity
found in the hemocyte lysate supernatant (Fig. 1). Significant
activation (p < 0.05) vs nontreated hemocytes was already
evident (65.9 ± 1.32) when the methylmercury concentration
was 10−6 M. The activity further increased (72.4 ± 1.1) at
10−5 mM and reached a high level (79.3 ± 1.3) at 10−4 M
(p < 0.01). This effect was similar to proPO activation due to
treatment with trypsin that is known to be the best activator
(89.1 ± 5.0, p < 0.001). Quinone production (Abs at 505 nm)
became asymptotic within 25–30 min after the addition of
DOPA-MBTH mixture (Fig. 1).
Effects of methylmercury on hemocyte cytotoxic
activity
Figure 2 shows the methymercury effect on cytotoxic
hemocytes assayed with REs in the presence of increasing
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Figure 1. Effect of various methylmercury concentrations on
the PO activity (A505) of hemocyte lysate supernatant after
S. plicata hemocytes were incubated for 1 h in vitro with
xenobiotic. Bars represent SD, n = 8. ∗p > 0.05; ∗∗p > 0.01;
∗∗∗p > 0.001.
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Figure 2. Effect of various methylmercury concentrations on
S. plicata hemocyte cytotoxic activity (HCA), against rabbit
erythrocytes after incubation of hemocytes for 1 h in vitro with
xenobiotic. Bars represent SD, n = 8. ∗p > 0.05; ∗∗p > 0.01;
∗∗∗p > 0.001.
methylmercury concentrations (10−8 –10−4 M). The activity
of 7.5 × 106 cells ml−1 (effector/target ratio, i.e. E : T = 1 : 5)
was significantly inhibited in a dose-dependent fashion,
reaching the lowest level at 10−4 M (p < 0.001), whereas, at
the lowest xenobiotic concentration (10−8 M), the inhibition
level presented a low significance value (p < 0.05; 21.82%)
compared with the control. The activity of the cells exposed
to higher concentrations (10−4 M) decreased by up to 19%
(p > 0.001). At different hemocyte numbers, the inhibition
ranged from about 50% (3.75 × 106 cell ml−1; E : T = 1 : 10)
to 38% (15 × 106 cell ml−1; E : T = 1 : 2.5) depending on the
effector : target ratio.
Effect of methylmercury on phagocytic activity
Figure 3(A, B) shows that the highest phagocytic activity
was achieved when 2.5 × 106 cells ml−1 were incubated with
yeast for 60 min at 20 ◦C. The effects on phagocytic activity of
hemocytes exposed in vitro to methylmercury are presented in
Fig. 3(C). Figure 3(D) shows hemocytes with phagocytosized
yeast as observed for their fluorescence. After just 1 h of
hemocyte incubation with the xenobiotic, the phagocytic
activity was significantly lowered (p < 0.05) by 10−8 and
10−7 M methylmercury, reaching the lowest level (p < 0.001)
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Figure 3. In vitro phagocytosis of yeast cells (Saccharomyces cerevisiae) by S. plicata hemocytes. Phagocytosis was evaluated as the
percentage of hemocytes contaning yeast (% phagocytosis). (A) Percentage of phagocytes in absence of xenobiotic; (B) phagocytic
response of hemocytes at different temperatures; (C) percentage of phagocytes after hemocyte exposure to different methylmercury
concentrations; (D) light microscopy observation of phagocytes (P); in the inset fluorescent yeasts (Y) are shown. Bar = 10 µm.
∗p > 0.05; ∗∗p > 0.01; ∗∗∗p > 0.001.
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in the presence of 10−6 M, and it was significantly decreased
by 10−5 M (p < 0.001).
Cell morphology modification after
methylmercury exposure
When 5 × 106 cell ml−1 hemocytes were layered in the wells of
a U-bottomed chamber containing decreasing methylmercury
concentrations (from 10−4 to 10−7 M), changes in cell
morphology and spreading appeared at a macroscopical
level as variously shaped disk of cells [Fig. 4(A)]. Microscopy
observations of the hemocytes layered on the well bottom
showed that, in the absence of methylmercury, the hemocytes
presented a spread shape showing an irregular morphology
[Fig. 4(B)]. After treatment with methylmercury at a low
concentration (10−4) the hemocytes presented a round shape
[Fig. 4(C)]. Similar results were obtained when treatments
were directly performed on a slide.
As shown in Fig. 4(D, E), PO-positive morula cells were
identified by cytochemical reaction with DOPA-MBTH. An
untreated spread morula cell is shown in Fig. 4(D), whereas
Fig. 4(E) presents a round methylmercury-treated cell with
more intense DOPA-MBTH stain.
Since PO-containing cells could release the enzyme after
methylmercury treatment, the PO activity of hemocyte culture
medium was compared with that of the cultured hemocytes.
Data listed in Table 1 show that the PO activity found in
the medium was significantly lower than that of the HLS.
In addition, cell treatment with methylmercury significantly
(p < 0.001) enhanced the activity of both the released (25%
enhancement) and cytoplasmic (27% enhancement) PO.
DISCUSSION
Tunicates are filter-feeding marine invertebrates ubiquitous
throughout the world. They live along the coast and can
be subjected to environmental contaminats such as toxic
metals, including the methylated form of mercury, that could
affect their innate immune system. According to previous
reports, xenobiotics could activate or suppress the immune
functions. A decreased immunoreactivity, i.e. phagocytosis
and cytotoxicity, affects the preservation of organism health,
whereas it is unclear if activation of components of the
immune system may affect the organism immunesurveillance
Table 1. PO activity of S. plicata hemocytes (107 cells ml−1)
treated for 1 h with 10−5 M methylmercury. Hemocyte culture
medium and hemocyte lysate supernatant (HLS) were
examined; n = 8
PO activity (UA505 mg−1 protein) Increase
Control Methylmercury (%)
Culture medium 35.4 ± 2.9 45.7 ± 2.8 (p < 0.001) (25.9)
HLS 63.3 ± 5.2 80.3 ± 3.2 (p < 0.001) (27.8)
MS 10-4 10-5 10-6 10-7
A
ED 
B
C
Figure 4. Effect of methylmercury on S. plicata hemocyte mor-
phology. (A) Macroscopical test of hemocytes from hemolymph
after 1 h of preincubation with different methylmercury concen-
trations; (B) control: hemocytes maintained for 1 h in marine
solution in absence of xenobiotic; (C) light microscopy obser-
vations of hemocytes after 1 h treatment with methymercury
(10−6 M); (D) phenoloxidase activity of hemocytes maintained
in MS in the absence of methylmercury, as revealed by
DOPA-MBTH mixture; (E) PO activity of hemocytes treated for
1 h with 10−6 M methylmercury, as revealed by MBTH mixture;
B and C, bar = 20 µm; D and E, spot bar = 10 µm.
capacity. In ascidians, phagocytosis,46 the prophenoloxidase
system42 and cytotoxic47 activities are the main cellular
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immune mechanisms exerted by hemocytes circulating in
the hemolymph for defending the organism against several
pathogens that could penetrate through pharynx filtrating
action. Ascidians undergo the effect of environmental
xenobiotics and bioaccumulate metals, becoming chronically
exposed to their action.
In the present paper, we examined the effects in vitro of
methylmercury, at sublethal concentrations, on Styela plicata
hemocyte phenoloxidase, cytotoxic and phagocytic activities.
In addition, since cell morphology and spreading hemocyte
ability can be related to immune functions, these features were
taken into consideration. The methylmercury concentrations
we used for examining the effect on immunocytes were
not toxic, as indicated by Trypan blue dead cell exclusion
test, while viability was not affected by the treatment,
as shown by the neutral red test. In general terms,
95% hemocytes maintained their main viable properties,
whereas immune functions were affected by the xenobiotic
compound. The phenoloxidase activity was examined in the
lysate supernatant from hemocytes treated with different
methylmercury amounts. In the range of 10−4 –10−8 M, the
xenobiotic enhanced the PO activity in a dose-dependent
fashion, suggesting that the pro-phenoloxidase system could
be activated even if at a level lower than that observed by a
treatment with a serine protease (trypsin), which is known to
be a good activator of the proPO pathway.48 Similar results
have been reported using fruoranthene on Mytilus edulis
hemocyte PO.49
In S. plicata, phenoloxidase activity is a property of
morula cells50 which, after effector–target contacts, display
PO-dependent cytotoxic activity against erythrocytes and
tumor line K562 cells, probably due to quinones produced
by the PO pathway.48 When hemocytes were pre-treated
with 10−5 M methylmercury, in spite of the PO activation, the
cytotoxic activity was inhibited, suggesting that the treatment
of hemocytes with the xenobiotic affects cell-target contacts,
including the recognition mechanism. Accordingly, a similar
xenobiotic action could be responsible for phagocytosis
inhibition. Phagocytes after 1 h exposition to low xenobiotic
concentration (10−4 up to 10−5 M), were viable but did not
phagocytosize yeast, whereas their activity was maintained
almost at control level when the cells were in the presence of
a lower toxicant concentration (10−8 M).
The cytotoxicity inhibitory effect could not be imputed to a
releasing mechanism, since in the presence of the xenobiotic
the enzyme was released into the culture medium showing the
same activity level as the controls. However, we do not know
if methylmercury could also act on cytoskeletal network, as
indicated by changes in hemocyte morphology and spreading
capacity. With regard to this, it is known that cytoskeletal
alterations lead to reduced phagocytic activity, due to the
decreased ability of hemocytes to adhere to the substrate and
interact with targets.51 Finally, a lipid peroxidation10 could
damage the plasma membrane, affecting the activity of both
phagocytes and cells of the cytotoxic line.
Effects on the cytoskeleton could be responsible for changes
in the hemocyte morphology and spreading capacity, as
revealed by the microplate assay we performed. Although
the assay cannot reveal the xenobiotic concentration values
in water, it appears to be an easy method for indicating
that xenobiotics at sublethal toxicant concentration could be
present.
In conclusion, we show that high environmental
methylmercury concentrations are toxic for tunicate hemo-
cytes, whereas sublethal concentrations affect the S. pli-
cata immunocyte activities, causing immunosuppression, as
revealed by assaying cytotoxic activity with rabbit erythro-
cytes and phagocytosis of yeast, which could be used as
additional immunotoxicology biomarkers in macrobenthic
studies.
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